Gas tonometry for evaluation of gastrointestinal mucosal perfusion: experimental and clinical sepsis¹. part 2

Tonometria a gás para a avaliação da perfusão da mucosa gastrointestinal: sepse clínica e experimental. Parte 2

a03v17n5

3 – SPECIAL REVIEW ARTICLE

GAS TONOMETRY FOR EVALUATION OF GASTROINTESTINAL MUCOSAL PERFUSION. EXPERIMENTAL AND CLINICAL SEPSIS¹. PART 2

Eliezer Silva²

Luiz Francisco Poli de Figueiredo³

Ruy Jorge Cruz Jr⁴

Maurício Rocha e Silva⁵

SilvaE, Poli de Figueiredo LF, Cruz JrRJ, Rocha e Silva M. Gas tonometry for evaluation of gastrointestinal mucosal perfusion: experimental and clinical sepsis. Part 2. Acta Cir Bras [serial online] 2002 Sept-Oct;17(5). Available from URL: http://www.scielo.br/acb

ABSTRACT - Substantial clinical and animal evidences indicate that the mesenteric circulatory bed, particularly the gut mucosa, is highly vulnerable to reductions in oxygen supply and prone to early injury in the course of hemodynamic changes induced by sepsis and septic shock. Gut hypoxia or ischemia is one possible contributing factor to gastrointestinal tract barrier dysfunction that may be associated with the development of systemic inflammatory response and multiple organ dysfunction syndrome, the principal cause of death after sepsis. Monitoring gut perfusion during experimental and clinical sepsis may provide valuable insights over new interventions and therapies highly needed to reduce multiple organ dysfunction and sepsis-related morbidity and mortality. We present our experience with gas tonometry as a monitor of the adequacy of gastrointestinal mucosal perfusion in experimental models sepsis and with the use of vasoactive agents for hemodynamic management in patients with septic shock.

KEY WORDS - Septic shock. Multiple organ failure. Tonometry. Sepsis. Catecholamines. Gut mucosa.

Severe sepsis and septic shock are associated with high morbidity and mortality, due to multiple organ dysfunction syndrome. Substantial clinical and animal evidences indicate that the mesenteric circulatory bed, particularly the gut mucosa, is highly vulnerable to reductions in oxygen supply and prone to early injury in the course of hemodynamic changes. We have presented our experience with gas tonometry in experimental models of trauma, shock and complex surgical maneuvers¹. We also analyzed the concepts of the tonometric method and how PCO₂ is a marker of blood flow and tissue hypoxia.¹ In the present issue, we further analyze the role of gas tonometry in experimental and clinical sepsis and septic shock.

PATHOPHYSIOLOGY OF TISSUE HYPERCARBIA IN SEPSIS

There are many reasons for the development of gastric mucosal hypercarbia in septic patients. Metabolic needs are typically increased by the inflammatory response to infection, increasing CO₂ load. This may further enlarge veno-arterial PCO₂ and tissue-arterial PCO₂ gradients, especially when there is no compensatory increase in cardiac output or tissue blood flow. Particularly during early resuscitation, tissue blood flow can be low (stagnant flow), due to either hypovolemia and/or arterial hypotension. Gastric mucosal hypercarbia may be also due to systemic metabolic acidosis, mainly secondary to lactic acidosis, condition in which tissue hypercarbia is universally observed, produced by bicarbonate buffering of hydrogen ions. Even in the absence of systemic acidosis, tissue CO₂ can be increased by anaerobic metabolism, due to regional blood flow maldistribution, shifting blood flow away from mucosa. Moreover, mucosal acidosis may not be mediated by hemodynamic alterations, but may be due to direct metabolic changes induced by endotoxin.² Increasing mucosal blood flow by hemodynamic interventions, in this condition, may fail to reestablish normal mucosal PCO₂. Finally, a paradoxical increase in PCO₂-gap may be observed, despite of an increase in mucosal blood flow and oxygen saturation. This phenomenon could be explained by the Haldane effect, which states that at any PCO₂, arterial oxygenated blood has a lower CO₂ content than reduced venous blood. Hence, for a given CO₂ content, PCO₂ will be higher at a higher hemoglobin saturation. Table 1 summarizes the main causes of elevated tissue CO₂.

SPLANCHNIC BLOOD FLOW DISTRIBUTION

Although pHi and PCO₂ gap are often considered as indexes of splanchnic perfusion,^3,4 this has never been shown conclusively. Some experimental and clinical studies have failed to demonstrate a linear correlation between gut mucosa PCO₂ and hepatosplanchnic blood flow. PCO₂ gap reflects merely perfusion and/or oxygenation conditions of the gut mucosa. Therefore, we cannot generalize gut mucosa CO₂ measurements to the splanchnic area, because blood flow distribution may vary widely between and within organs, especially in sepsis.

Vallet et al.⁵ demonstrated, in a canine model of resuscitated endotoxic shock, a marked redistribution of blood flow within the gut wall, from the mucosa toward the muscularis, with a simultaneous decrease in intestinal mucosal PO₂. These data contrast with Revelly et al.,⁶ who used microspheres to evaluate blood flow distribution within the intestinal wall during endotoxic shock in pigs. Surprisingly, they found that, whereas total mesenteric blood flow was unchanged, blood flow to gut mucosa increased and blood flow to the muscularis decreased. Although marked blood flow redistribution was observed in both studies, their opposite findings could be explained by differences in the methods used to assess mucosal blood flow.

We have recently evaluated the effects of large volume infusion on splanchnic blood flow distribution, using live E. coli infusion in dogs (Figure 1). After bacteria infusion, cardiac index (CI) and mesenteric blood flow (MBF, ultrasonic flowprobe) decreased. In contrast, portal-arterial PCO₂ and gastric-arterial PCO₂ (PCO₂ gap) gradients increased. After fluid resuscitation, whereas CI and MBF increased and portal-arterial PCO₂ gradient decreased, PCO₂ gap remained high (Figure 1). If we use CO₂ gradient as a marker of blood flow, we should analyze the behavior of CO₂ gradient in different compartments. There was no correlation between systemic venous-arterial PCO₂, portal-arterial PCO₂, and PCO₂ gap, probably reflecting a large blood flow redistribution within these compartments.

Similar findings have emerged from clinical studies. In stable septic patients, Creteur et al.⁷ found no significant correlation between PCO₂ gap and hepatosplanchnic blood flow, or between PCO₂ gap and other regional oxygen-derived variables, such as suprahepatic venous blood oxygen saturation and mesenteric veno-arterial PCO₂ gradient. We have studied the effects of norepinephrine and epinephrine infusion on systemic hemodynamic variables, hepatosplanchnic blood flow and gastric mucosal PCO₂ in septic shock patients, and no correlation between them could be demonstrated.⁸ For instance, epinephrine infusion increased CI more than norepinephrine, but fractional splanchnic blood was higher with norepinephrine. If the increase in splanchnic blood flow occurred similarly in all gut layers, DPCO₂ gap and DSvO₂-ShO₂ would decrease proportionally, because SvO₂-ShO₂ gradient reflects the oxygenation balance in the splanchnic area. However, no correlation between DPCO₂ gap and DSvO₂-ShO₂ gradient was observed (Figure 2). Our findings support the concept that there is a large blood flow redistribution inter and intra-organs in septic states.⁸

In summary, gut mucosal PCO₂ is just a surrogate marker of local blood flow, reflecting merely the balance between CO₂ production and clearance within that layer of the gastrointestinal tract. Actually, we should interpret gut mucosal PCO₂ as a tool to better understand blood flow distribution in sepsis and its possible clinical implications.

CLINICAL USES OF GASTRIC TONOMETRY IN SEPSIS

Since gut mucosal hypoperfusion may have a pivotal role in the development of multiple organ dysfunction in sepsis, several authors are attempting to correlate gastric tonometry with outcome. Consequently, many studies have also addressed if gastric acidosis reversal could affect outcome and its response to potential hemodynamic interventions.

Outcome prediction

Gastric intramucosal acidosis, detected during intensive care admission, has been related to outcome in several trials.^9-13 It's predictive value, after an initial period of treatment in the intensive care unit, has been conflicting. However, those trials have several limitations. The number of patients that has been enrolled is not enough to exclude neither a beta nor an alfa error. Moreover, there is a large heterogeneity regarding inclusion criteria. Mortality has been the main endpoint, which is subject to many influences other than the ones directly related to the restoration of organ perfusion. Finally, most studies have been using calculated pHi, which incorporates systemic bicarbonate, therefore impairing comparison between the effects of systemic and regional perfusion disturbances on outcome, as previously discussed.

Preliminary results from our prospective, ongoing study in patients with severe sepsis and/or septic shock (ACCP/SCCM consensus conference definition), have been suggesting a relationship between PCO₂ gap and the development of multiple organ dysfunction, assessed by SOFA score.¹⁴ We have already evaluated 44 patients with ages varying between 15-85 years old. Mortality rate has been 40% and APACHE II score, 19. Patients who had a PCO₂-gap larger than 15 mm Hg, at the 3^rd day following resuscitation, either had a high SOFA score (>11) or died by the 10^th day. An interesting finding has been that patients with a sustained high PCO₂ gap are showing a progressive increase in relative risk for death, on days zero, 1 and 2 (Table 2). Similarly, high SOFA score was associated with mortality.¹⁴ However, caution must be exercised in interpreting these data, because gastric mucosa acidosis could be just a marker of sepsis-induced dysfunction in cellular metabolism, instead of the cause of multiple organ failure, as has been widely claimed. Additional clinical trials are needed to confirm and better clarify this relationship.

HEMODYNAMIC MANAGEMENT OF GASTRIC MUCOSAL ACIDOSIS IN SEPTIC PATIENTS

From the preceding discussion, it seems atractive to attempt to reduce intestinal microcirculation abnormalities in sepsis. A reasonable hypothesis to be tested is that the use of vasoactive agents, which optimize intestinal perfusion, can reduce the incidence of MODS in septic patients.^5,15

Total hepatosplanchnic blood flow, measured by indocianine green technique, and mucosal blood flow, measured directly by laser Doppler or indirectly by gas tonometry, have been used to assess regional oxygenation during the most commonly used hemodynamic interventions in sepsis, fluid replacement and vasoactive drug infusion.

Absolute or relative hypovolemia is commonly present in septic patients and it is responsible, in part, for tissue hypoperfusion, justifying why fluid replacement is considered an essential, early intervention in sepsis. However, the relationship between fluid resuscitation and gastric mucosal blood flow remains incompletely characterized. Actual knowledge is largely based on experimental studies. In an endotoxic shock model in dogs, De Backer et al.¹⁵ showed that fluid resuscitation increased mesenteric blood flow but did not prevent the decrease in gastric mucosal pH. Also in endotoxemic dogs, Vallet et al.¹⁷ showed that fluid resuscitation increased cardiac output and gut serosal PO₂, and restored systemic VO₂; however, gut VO₂, mucosal PO₂ and pHi remained low and gut lactate output high. We evaluated systemic and regional effects of fluid resuscitation in dogs with sepsis induced by live E. coli infusion. Crystalloid infusion restored both systemic and global regional variables, such as superior mesenteric artery blood flow and portal vein-arterial PCO₂.gradient. However, fluid infusion only avoided further increases in PCO₂ gap, with no improvement after 60 minutes (Figure 1).

Data from clinical studies are very limited. In a small group of hypovolemic septic patients, Forrest et al.¹⁸ reported that fluid loading neither increased pHi nor decreased PCO₂ gap. Addressing the repercussion of a fluid challenge (500 mL of hetastarch over 30 minutes), on systemic hemodynamic parameters and PCO₂ gap in patients with severe sepsis or septic shock, we did show a decrease in mean PCO₂ gap.¹⁹ However, significant individual variations in PCO₂ gap response were observed and there was no correlation between changes in cardiac index and PCO₂ gap. These data suggest that PCO₂ gap should not be used isolated to guide fluid replacement.

When tissue oxygenation is not restored despite fluid replacement, vasoactive drugs are commonly used to increase oxygen supply and avoid hypotension. However, they induce different changes on systemic and regional blood flow. We reviewed the effects of vasoactive drugs on gastric pHi.²⁰ Within the inherent limitations with the use of pHi, in most studies, as the gut mucosal perfusion index, we highlighted that a) although dopaminergic effects can increase splanchnic blood flow, low-dose dopamine usually decreases pHi, suggesting a blood flow redistribution away from gastric mucosa; b) dobutamine most commonly increases splanchnic blood flow and tends to increase pHi in septic patients. In addition, dobutamine can disclose the presence of severe splanchnic hipoperfusion in septic patients. Creteur et al.²¹ showed that, in patients with low fractional splanchnic blood flow (SBF/cardiac index), the PCO₂ gap fell significantly with increasing doses of dobutamine; c) dopexamine has been shown to increase splanchnic oxygenation, principally in sepsis, but it can also induce undesirable hypotension; d) data on norepinephrine are more limited, but suggest that it can increase pHi in patients with septic shock; and e) epinephrine could impair splanchnic perfusion in patients with septic shock. More recent data support the benefits of beta-adrenergic agents on gastric mucosal perfusion.^22,23 These data can be summarized by a commonly employed statement "beta-adrenergic effects have a pivotal role in increasing gut mucosal blood flow in sepsis".

Targeting the intestinal microcirculation with vasoactive drugs is one approach to counteract the microvascular abnormalities in the pathophysiology of sepsis. However, major individual variations are present in several studies including ours.^19-21,24 Clinicians must exercise prudence to incorporate these evidences in clinical practice and should test different doses of distinct cathecolamines to achieve their physiological therapeutic aims.

GAS TONOMETRY GUIDED-THERAPY

In critically ill patients, a persistently high PCO₂ gap may be associated with worsening in outcome but it has not been definitively established if this finding is just an epiphenomenon or a pathophysiological event of the development of multiple organ dysfunction. However, in evidence-based medicine (EBM) époque, clinicians have claimed for a large multicenter randomized clinical trial, proving or disproving the effectiveness of PCO₂ gap-guided therapy, before actively incorporating its use in the daily practice.

To date, only five controlled studies have examined whether treatment aimed to increase pHi improve outcome. None of them addressed exclusively septic patients and only two enrolled an expressive number of patients to allow drawing some conclusion. Gutierrez et al.²⁵ performed a randomized, controlled clinical trial comparing standard therapy (not specified) to additional therapy, described as further fluid and red blood cell replacements plus dobutamine infusion, to correct low pHi in critically ill patients. They showed that mortality rate was significantly reduced in those patients with an admission pHi of > 7.35. More recently, Gomersall et al.,²⁶ using a more controlled resuscitation protocol, sought if additional therapy, aimed at correcting low pHi, would improve outcome in conventionally treated critically ill patients. In this study, pHi guided-therapy failed to improve outcome. However, both studies, enrolled heterogeneous groups of patients. As one would expect, it is not probable that an isolated, miraculous intervention for different patients could produce outcome improvement. In the Gutierrez's study, mortality in the control group was unexpectedly high, and no attempt was made to standardize treatment.²⁵ In Gomersall's study, there was no difference in pHi between control and intervention groups at zero, 12, and 24 hours, when the intervention was withhold.²⁶ We have demonstrated that persistent gastric mucosal acidosis, beyond 24 hours, is very important to predict outcome.¹⁴ So, treatment protocol could be maintained until 48 or 72 hours after the beginning of resuscitation. Finally, as mentioned, the use of calculated pHi incorporates systemic metabolic and respiratory variables, compromising the interpretation of pHi as a regional parameter to be targeted.

Recently, Chapman et al.²⁷ published the state of the art on gastrointestinal tonometry. The authors emphasized that, while it may be possible to apply the principles of evidence-based medicine to the evaluation of a single intervention affecting outcome, applying them to the introduction of a new piece of monitoring is even more complex. It is the management driven by and the therapeutic interventions taken in response to the monitor's information which may affect outcome. Both are dependent on many other factors, not simply the numbers displayed on the monitor's screen. For an example, pulse oximetry would not be used in clinical setting based on these principles, because there was no difference in outcome or complication rate with its use. However, it was shown that it allows a rapid, early and safe diagnosis, and correction of arterial hypoxemia with significantly less supplemental oxygen than with the group of patients without pulse oximetry. The same may be true for gas tonometry, which may provide information guiding interventions leading to the reversal of disturbances that may be linked to multiple organ dysfunction.

CONCLUSIONS

There are clinical and experimental evidences that support the relationship between splanchnic hypoperfusion and multiple organ dysfunction in patients and animals submitted to sepsis, shock, trauma or complex surgical procedures, largely related to mucosal injury leading to increased permeability and systemic inflammatory response. As gut mucosal pCO₂ reflects the balance between flow and metabolism, gas tonometry is a valuable tool to monitor regional effects of hemodynamic interventions and gives insights regarding blood flow heterogeneity in distinct shock states. The definitive role of gas tonometry to predict outcome and guide therapy for patients with trauma, sepsis or submitted to complex operations, will be established by large, prospective multicenter trials.

SilvaE, Poli de Figueiredo LF, Cruz JrRJ, Rocha e Silva M. Tonometria a gás para a avaliação da perfusão da mucosa gastrointestinal: sepse clínica e experimental. Parte 2. Acta Cir Bras [serial online] 2002 Set-Out;17(5). Disponível em URL: http://www.scielo.br/acb

RESUMO - Evidências clínicas e experimentais substanciais indicam que o território circulatório mesentérico, principalmente na mucosa intestinal, é altamente vulnerável a redução na oferta de oxigênio e predisposto a lesão precoce na presença de alterações hemodinâmicas induzidas pela sepse e choque séptico. A hipóxia ou isquemia intestinal é um dos possíveis mecanismos contribuintes para a disfunção da barreira gastrointestinal que pode estar associada com o desenvolvimento da resposta inflamatória sistêmica e com a síndrome da disfunção de múltiplos órgãos, a principal causa comum de morte na sepse. Monitorar a perfusão intestinal na sepse experimental e clínica pode fornecer dados valiosos quanto a novas intervenções e tratamentos altamente necessários para reduzir disfunção de múltiplos órgãos e mortalidade extremamente elevadas na sepse. Apresentamos nossa experiência com a tonometria a gás como monitor da adequação da perfusão da mucosa gastrointestinal na sepse clínica e experimental, e com o uso de drogas vasoativas no controle hemodinâmico em pacientes com choque séptico.

DESCRITORES - Choque séptico. Falência de múltiplos órgãos. Tonometria. Sepse. Catecolaminas. Mucosa intestinal.

Conflito de interesse: nenhum

Fonte de financiamento: FAPESP

Address for correspondence:

Luiz F Poli de Figueiredo

Heart Institute (InCor), Univ. São Paulo Medical School

Av. Enéas de Carvalho Aguiar, 44

05403-000 - São Paulo - SP

Phone: [phone] Fax: [phone]

[e-mail]

Data do recebimento: 28/02/2002

Data da revisão: 21/05/2002

Data da aprovação: 22/05/2002

• 1. Poli de Figueiredo LF, Silva E, Cruz Jr RJ, Rocha e Silva M. Gas tonometry for evaluation of gastrointestinal mucosal perfusion: experimental models of trauma, shock and complex surgical maneuvers. Part 1. Acta Cir Bras [serial online] 2002 July-Aug;17(4). Available from URL: http://www.scielo.br/acb
• 2. Van der Meer JT, Wang H, Fink MP. Endotoxemia causes ileal micosal acidosis in the absence of mucosal hypoxia in a normodynamic porcine model of septic shock. Crit Care Med 1995; 23:1217-26.
• 3. Maynard N, Bihari D, Beale R, Smithies M, Baldock G, Mason R et al. Assessment of splanchnic oxygenation by gastric tonometry in patients with acute circulatory failure. J Am Med Assoc 1993;270:1203-10.
• 4. Maynard ND, Bihari DJ, Dalton RN, Smithies MN, Mason RC. Increasing splanchnic blood flow in the critically ill. Chest 1995;108:1648-54.
• 5. Vallet B, Teboul JL, Cain SM, Curtis SE. Veno-arterial CO2 difference during regional ischemic or hypoxic hypoxia. J Appl Physiol 2000;89:1317-21.
• 6. Revelly JP, Ayuse A, Brienza N, et al. Endotoxic shock alters distribution of blood flow within the intestinal wall. Crit Care Med 1996;24:1345-51.
• 7. Creteur J, De Backer D, Vincent JL. Does gastric tonometry monitor splanchnic perfusion? Crit Care Med 1999;27:2480-4.
• 8. Silva E, Creteur J, De Backer D, Vincent JL. Effects of norepinephrine and epinephrine on splanchnic oxygen utilization in septic shock patients. Crit Care Med 1998;26:A63.
• 9. Doglio GR, Pusajo JF, Egurrola MA, Bonfigli GC, Parra C, Vetere L et al. Gastric mucosal pH as a prognostic index of mortality in critically ill patients. Crit Care Med 1991;19:1037-40.
• 10. Mohsenifar Z. Gastric intramucosal acidosis during weaning from mechanical ventilation. Adv Exp Med Biol 1994; 361:333-43.
• 11. Gutierrez G, Palizas F, Doglio G, Wainsztein N, Gallesio A, Pacin J et al. Gastric intramucosal pH as a therapeutic index of tissue oxygenation in critically ill patients. Lancet 1992;339(8787):195-9.
• 12. Marik PE. Gastric intramucosal pH. A better predictor of multiorgan dysfunction syndrome and death than oxygen-derived variables in patients with sepsis. Chest 1993;104:225-9.
• 13. Joynt GM, Lipman J, Gomersall CD, Tan I, Scribante J. Gastric intramucosal pH blood lactate in severe sepsis. Anaesthesia 1997;52:726-32.
• 14. Silva E, Blecher S, Kai MH, Assumcao MC, Martins PS, Rigato Jr O, Garrido AG, Knobel E. Gastric-arterial PCO2 gradient, but not lactate levels, is related to multiple organ dysfunction assessed by SOFA score in septic patients n septic shock. Crit Care Forum 2000;4:S88.
• 15. Vallet B, Durinck JL, Chagnon JL, Neviere R. Effects of hypoxic hypoxia on veno and gut mucosal arterial PCO2 difference in pigs. Anesthesiology 1996;85:A607.
• 16. De Backer D, Zhang H, Manikis P, Vincent JL. Regional effects of dobutamine in endotoxic shock. J Surg Res 1996;65:93-100.
• 17. Vallet B, Lund N, Curtis SE, et al. Gut and muscle tissue PO2 in endotoxemic dogs during shock and resuscitation. J Appl Physiol 1994;76:793-800.
• 18. Forrest DM, Baigorri F, Chittock DR, Spinelli JJ, Russell JA. Volume expansion using pentastarch does not change gastric arterial CO2 gradient or gastric intramucosal pH in patients who have sepsis syndrome. Crit Care Med 2000;28:2254-8.
• 19. Silva E, De Backer D, Creteur L, Vincent JL. Effects of fluid challenge on gastric-arterial CO2 gradient in septic patients. Crit Care Med 1998;26:A136.
• 20. Silva E, DeBacker D, Creteur J, Vincent JL. Effects of vasoactive drugs on gastric intramucosal pH. Crit Care Med 1998;26:1749-58.
• 21. Creteur J, De Backer D, Vincent JL. A dobutamine test can disclose hepatosplanchnic hypoperfusion in septic patients. Am J Respir Crit Care Med 1999;160:839-45.
• 22. Duranteau J, Sitbon P, Teboul JL, Vicaut E, Anguel N, Richard C et al. Effects of epinephrine, norepinephrine, or the combination of norepinephrine and dobutamine on gastric mucosa in septic shock. Crit Care Med 1999;27:893-900.
• 23. Levy B, Bollaert PE, Luchelli J-P, Sadoune L-D, Larcan A. Dobutamine improves the adequacy of gastric mucosal perfusion in epinephrine-treated septic shock. Crit Care Med 1997;25:1649-54.
• 24. Levy B, Nace L, Bollaert PE, Dousset B, Mallie JP, Larcan A. Comparison of systemic and regional effects of dobutamine and dopexamine in norepinephrine-treated septic shock. Intensive Care Med 1999;25:942-8.
• 25. Gutierrez G, Palizas F, Doglio G, Wainsztein N, Gallesio A, Pacin J et al. Gastric intramucosal pH as a therapeutic index of tissue oxygenation in critically ill patients [see comments]. Lancet 1992; 339(8787):195-9.
• 26. Gomersall CD, Joynt GM, Freebairn RC, Hung V, Buckley TA, Oh TE. Resuscitation of critically ill patients based on the results of gastric tonometry: a prospective, randomized, controlled trial. Crit Care Med 2000;28:607-14.
• 27. Chapman M, Mythen MG, Webb AR, Vincent JL. Report from the meeting: gastrointestinal tonometry: state of the art. Intensive Care Med 2000;26:613-22.

1. Studies performed at the Hospital Erasme, Free University of Brussels, Intensive Care Unit, Hospital Israelita Albert Einstein, and Division of Applied Physiology, Dept. of Cardiopneumology, Heart Institute, InCor, Univ. São Paulo Medical School, São Paulo, Brazil

. Studies performed at the Hospital Erasme, Free University of Brussels, Intensive Care Unit, Hospital Israelita Albert Einstein, and Division of Applied Physiology, Dept. of Cardiopneumology, Heart Institute, InCor, Univ. São Paulo Medical School, São Paulo, Brazil 2. Professor, Internal Medicine, Univ. Santo Amaro and Posdoctoral Fellow, Heart Institute, InCor, Univ. São Paulo Medical School 3. Associate Professor, Division of Applied Physiology, Heart Institute, InCor, Univ. São Paulo Medical School, and Department of Surgery, UNIFESP/EPM, São Paulo, Brazil 4. Doctoral Fellow, Division of Applied Physiology, Heart Institute, InCor, Univ. São Paulo Medical School 5. Chairman, Department of Cardiopneumology, Heart Institute, InCor, Univ. São Paulo Medical School

Publication Dates

• Publication in this collection
  03 Sept 2003
• Date of issue
  Sept 2002

History

• Accepted
  22 May 2002
• Reviewed
  21 May 2002
• Received
  28 Feb 2002